Savant Capital LLC Acquires 1,751 Shares of Astera Labs, Inc. $ALAB

Savant Capital LLC lifted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 115.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,267 shares of the company’s stock after acquiring an additional 1,751 shares during the quarter. Savant Capital LLC’s holdings in Astera Labs were worth $543,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Assetmark Inc. grew its stake in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Hilltop National Bank lifted its position in shares of Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after acquiring an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new position in shares of Astera Labs in the fourth quarter worth $33,000. National Bank of Canada FI grew its position in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares in the last quarter. Finally, Wexford Capital LP purchased a new position in shares of Astera Labs in the third quarter valued at $39,000. 60.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on ALAB shares. Stifel Nicolaus increased their price objective on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 target price for the company. Loop Capital initiated coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. JPMorgan Chase & Co. raised their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 28,737 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This represents a 0.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,298,757 shares of company stock worth $472,787,436 in the last quarter. 10.40% of the stock is owned by insiders.

Astera Labs Stock Down 1.5%

NASDAQ ALAB opened at $358.05 on Friday. The stock’s 50-day simple moving average is $209.01 and its two-hundred day simple moving average is $170.57. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $372.37. The company has a market capitalization of $61.37 billion, a price-to-earnings ratio of 241.93, a PEG ratio of 4.81 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.